Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2013

Mar 4, 2013

5262_dirs_2013-03-04_283a9a50-0e00-42a0-a65f-92aceaf3b1cd.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2024Z

GlaxoSmithKline PLC

04 March 2013

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the interests of the connected persons of Persons Discharging Managerial Responsibility, in the Ordinary Shares and American Depositary Shares (ADS) of GlaxoSmithKline plc following the sale of Ordinary Shares and ADS at a price of £14.55 per Ordinary Share and of $44.03 per ADS on 1 March 2013, to meet their tax liabilities following the vesting of awards granted in 2010 under the GlaxoSmithKline Share Value Plan:

Name of

PDMR
Name of Connected Person Number of Shares sold Number of Shares retained
Mr P Thomson Mrs K Thomson 436 (Ordinary Shares) 401 (Ordinary Shares)
Dr M Slaoui* Mrs K Slaoui 230 (ADS) 410 (ADS)

* Denotes an Executive Director

The Company and the above individuals were advised of these transactions on 1 March 2013.

This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).

V A Whyte

Company Secretary

4 March 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSVZLFBXXFLBBQ